ZFIN Image: Uribe et al., 2023, Fig. 4

Image

Figure Caption

Fig. 4 MM-201 does not alter the bactericidal activity of gentamicin, kanamycin, or neomycin as measured by the Kirby-Bauer Assay. (A) Co-treatment with one of a range of MM-201 concentrations (100 pM-10 µM) does not alter the area of inhibited E. coli growth surrounding the treatment-soaked disk (Two-way ANOVA; MM-201: F_{6, 139}=0.7523 p = 0.6086). (B) MM-201 does not alter bactericidal activity of gentamicin, kanamycin, or neomycin against S. aureus (Two-way ANOVA; MM-201: F_6,56=0.5474 p = 0.7699). (C) MM-201 does not alter bactericidal activity of gentamicin against P. aeruginosa (Two-way ANOVA; MM-201: F_6,28=0.7975 p = 0.5800). N = 6 disks per treatment, and error bars represent + s.d.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Reprinted from Hearing Research, 434, Uribe, P.M., Hudson, A.M., Lockard, G., Jiang, M., Harding, J., Steyger, P.S., Coffin, A.B., Hepatocyte growth factor mimetic confers protection from aminoglycoside-induced hair cell death in vitro, 108786108786, Copyright (2023) with permission from Elsevier. Full text @ Hear. Res.